• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment options and considerations for the newly diagnosed myeloma patient.

作者信息

Rajkumar Vincent S

机构信息

Division of Hematology, Mayo Clinic Medical College, Rochester, Minnesota, USA.

出版信息

Oncology (Williston Park). 2005 Sep;19(10):1260, 1262, 1267 passim.

PMID:16285223
Abstract
摘要

相似文献

1
Treatment options and considerations for the newly diagnosed myeloma patient.
Oncology (Williston Park). 2005 Sep;19(10):1260, 1262, 1267 passim.
2
Treatment paradigms for the newly diagnosed patient with multiple myeloma.新诊断的多发性骨髓瘤患者的治疗模式
Semin Hematol. 2005 Oct;42(4 Suppl 4):S16-21. doi: 10.1053/j.seminhematol.2005.10.002.
3
Tumor lysis syndrome following thalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.沙利度胺和地塞米松治疗新诊断多发性骨髓瘤后的肿瘤溶解综合征
Exp Hematol. 2006 Dec;34(12):1616. doi: 10.1016/j.exphem.2006.07.010.
4
Eastern Cooperative Oncology Group E1A00: phase III randomized study of dexamethasone with or without thalidomide in patients with newly diagnosed multiple myeloma.东部肿瘤协作组E1A00：地塞米松联合或不联合沙利度胺用于新诊断多发性骨髓瘤患者的III期随机研究。
Clin Adv Hematol Oncol. 2003 Mar;1(3):188-9.
5
Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group.沙利度胺联合地塞米松与单独使用地塞米松治疗新诊断多发性骨髓瘤的III期临床试验：一项由东部肿瘤协作组协调的临床试验
J Clin Oncol. 2006 Jan 20;24(3):431-6. doi: 10.1200/JCO.2005.03.0221. Epub 2005 Dec 19.
6
Toxic epidermal necrolysis following thalidomide and dexamethasone treatment for multiple myeloma: a case report.
Ann Hematol. 2010 Apr;89(4):421-2. doi: 10.1007/s00277-009-0810-y. Epub 2009 Aug 20.
7
Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial.沙利度胺与地塞米松联合治疗新诊断的未接受前期自体干细胞移植的多发性骨髓瘤患者：一项II期试验。
Haematologica. 2005 Dec;90(12):1650-4.
8
Prevention of venous thromboembolism with low molecular-weight heparin in patients with multiple myeloma treated with thalidomide and chemotherapy.在接受沙利度胺和化疗的多发性骨髓瘤患者中使用低分子量肝素预防静脉血栓栓塞
Leukemia. 2004 Dec;18(12):2044-6. doi: 10.1038/sj.leu.2403533.
9
[Efficacy of thalidomide combined dexamethasone on newly diagnosed multiple myeloma].沙利度胺联合地塞米松治疗初诊多发性骨髓瘤的疗效
Ai Zheng. 2007 Dec;26(12):1369-72.
10
Bisphosphonates may potentiate effects of thalidomide-dexamethasone combination in advanced multiple myeloma.
Am J Hematol. 2006 May;81(5):385-6; author reply 386. doi: 10.1002/ajh.20617.